Home | MyCME | All CME | Blog | Psychlopedia
​CME From JCP and PCC
Multimedia | CME From JCP | JCP Supplement | CME From PCC

CME From JCPScheduling an outpatient mental health appointment is a widely recommended discharge planning practice, but little is known regarding how often this practice is followed or its effectiveness. Find answers in this journal CME activity. [top]

JCP CME Activities

Effect of Scheduling a Post-Discharge Outpatient Mental Health Appointment on the Likelihood of Successful Transition From Hospital to Community-Based Care

Thomas E. Smith

Omega-3 Fatty Acid Supplementation for Perinatal Depression: A Meta-Analysis

Roel J. T. Mocking, Katja Steijn, Carolien Roos, Johanna Assies, Veerle Bergink, Henricus G. Ruhé, Aart H. Schene

Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder: A Systematic Review

Michelle J. Blumberg, Sophie R. Vaccarino, Shane J. McInerney

Characterization of the Quality of Electroconvulsive Therapy Among Older Medicare Beneficiaries

Taeho Greg Rhee; Mark Olfson; Kyaw Sint; Samuel T. Wilkinson

Efficacy, effect on mood symptoms, and safety of deep brain stimulation in refractory obsessive-compulsive disorder: a systematic review and meta-analysis

Filipe Peste Martinho, Gonçalo Silva Duarte, Frederico Simões do Couto

Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie

Georgios Schoretsanitis, John M. Kane, Christoph U. Correll, Stephen R. Marder, Leslie Citrome, John W. Newcomer, Delbert G. Robinson, Donald C. Goff, Deanna L. Kelly, Oliver Freudenreich, Daria Piacentino, Michael Paulzen, Andreas Conca, Gerald Zernig, Ekkehard Haen, Pierre Baumann, Christoph Hiemke, Gerhard Gründer, for the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrier

New-Onset Delusions Heralding an Underlying Neurodegenerative Condition: A Case Report and Review of the Literature

Emily A. Ferenczi; Michael G. Erkkinen; Mel B. Feany; Barry S. Fogel; Kirk R. Daffner

Disordered Aggression and Violence in the United States

Emil F. Coccaro, and Royce J. Lee

The Value of Neuropsychological Assessment in the Differentiation Between Behavioral Variant Frontotemporal Dementia and Late-Onset Psychiatric Disorders

Jozefien M. Overbeek; Nicole Korten; Flora Gossink; Jay Fieldhouse; Marleen van de Beek; Lianne Reus; Annemieke Dols; Yolande Pijnenburg; and Sigfried Schouws

Past Psychiatric Conditions as Risk Factors for Postpartum Depression: A Nationwide Cohort Study

Sara L. Johansen; Ben A. Stenhaug; Thalia K. Robakis; Katherine E. Williams; and Mark R. Cullen

Predicting Remission in Late-Life Major Depression: A Clinical Algorithm Based Upon Past Treatment History

Erica L. F. Buchalter; Hanadi Ajam Oughli; Eric J. Lenze; David Dixon; J. Philip Millera; Daniel M. Blumberger; Jordan F. Karp; Charles F. Reynolds III; and Benoit H. Mulsant

Prescription Opioid Misuse in US Older Adults: Associated Comorbidities and Reduced Quality of Life in the National Epidemiologic Survey of Alcohol and Related Conditions-III

Ty S. Schepis, and Sean Esteban McCabe

Real-World Outcomes in the Management of Refractory Psychosis

Amir Krivoy; Dan Joyce; Derek Tracy; Fiona Gaughran; James MacCabe; John Lally; Whiskey Eromona; S. Neil Sarkar, and Sukhwinder S. Shergill

Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis

Sally Mustafa; Ridha Joober; Srividya Iyer; Jai Shah; Martin Lepage; Ashok Malla

High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder

Christine Li; Boris Birmaher; Brian Rooks; Mary Kay Gill; Heather Hower; David A. Axelson; Daniel P. Dickstein, MD; Tina R. Goldstein; Fangzi Liao; Shirley Yen; Jeffrey Hunt; Satish Iyengar; Neal D. Ryan; Michael A. Strober; Martin B. Keller; and Benjamin I. Goldstein

Benzodiazepine Use During Pregnancy Alone or in Combination With an Antidepressant and Congenital Malformations: Systematic Review and Meta-Analysis

Sophie Grigoriadis; Lisa Graves; Miki Peer; Lana Mamisashvili; Cindy-Lee Dennis; Simone N. Vigod; Meir Steiner; Cara Brown; Amy Cheung; Hiltrud Dawson; Neil Rector; Melanie Guenette; and Margaret Richter

Treatment of Common Mental Disorders in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III

Mark Olfson, Carlos Blanco, Melanie M. Wall, Shang-Min Liu, and Bridget F. Grant

Sex and Pubertal Status Moderate the Association Between ADHD and Depression Symptoms: An Examination from Preadolescence Through Late Adolescence

Dara E. Babinski, Daniel A. Waschbusch, and James G. Waxmonsky

Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence

Roger D. Weiss, Margaret L. Griffin, David E. Marcovitz, Blake T. Hilton, Garrett M. Fitzmaurice, R. Kathryn McHugh, and Kathleen M. Carroll

Sexually Transmitted Infection Among Adolescents and Young Adults With Bipolar Disorder: A Nationwide Longitudinal Study

Mu-Hong Chen, Han-Ting Wei, Ya-Mei Bai, Kai-Lin Huang, Nai-Ying Ko, Tung-Ping Su, Cheng-Ta Li, Wei-Chen Lin, Shih-Jen Tsai, Tzeng-Ji Chen, and Ju-Wei Hsu

Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis

Eric T. Dobson, Michael H. Bloch, and Jeffrey R. Strawn

Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort

David Misdrahi, Arnaud Tessier, Antoine Daubigney, Wassilios G. Meissner, Franck Schurhoff, Laurent Boyer, Ophélia Godin, Ewa Bulzacka, Bruno Aouizerate, Meja Andrianarisoa, Fabrice Berna, Delphine Capdevielle, Isabelle Chereau-Boudet, Thierry D’Amato, Caroline Dubertret, Julien Dubreucq, Catherine Faget-Agius, Christophe Lançon, Jasmina Mallet, Christine Passerieux, Romain Rey, Aurélie Schandrin, Mathieu Urbach, Pierre Vidailhet, Pierre-Michel Llorca, and Guillaume Fond for the FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group

Blood Lithium Monitoring Practices in a Population-Based Sample of Older Adults

Soham Rej, Nathan Herrmann, Andrea Gruneir, Racquel Jandoc, Eric McArthur, Stephanie Dixon, and Amit X. Garg

A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice

Brian Shiner, Christine Leonard Westgate, Jiang Gui, Shira Maguen, Yinong Young-Xu, Paula P. Schnurr, and Bradley V. Watts

The Schizophrenia Remission Roller Coaster: Using Long-Acting Injectable Antipsychotics to Improve Adherence and Enhance Potential for Functional Recovery

Using Long-Acting Injectable Antipsychotics to Enhance the Potential for Recovery in Schizophrenia

Christoph U. Correll, MD, and John Lauriello, MD

Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment

Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment

Leslie Citrome, MD, MPH, and Stephen R. Saklad, PharmD, BCPP

Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia

Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia

Joseph P. McEvoy, MD, and Daniel E. Kremens, MD, JD

A Multidisciplinary Approach for Addressing Challenges in Alzheimer’s Disease

Current and Emerging Solutions to Challenges in the Management of Alzheimer’s Disease

Alireza Atri, MD, PhD (Chair); Danielle Goldfarb, MD; Simon Sheard, DO; and Lynn Shaughnessy, PsyD

Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia

Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia

John M. Kane, MD, and Christoph U. Correll, MD

Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia

Enhancing the Treatment of Patients With Schizophrenia Through Continuous Care

John Lauriello, MD, and Diana O. Perkins, MD

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment

Christoph U. Correll, MD (Chair); John M. Kane, MD; and Leslie L. Citrome, MD, MPH

CME From PCCDoes the capacity to consent vary between medical and psychiatric patients? Are tools needed to assess the patient’s decision-making capacity, or can the provider’s assessment be relied upon? Review the results of a study that sought answers to these questions in this CME journal activity. [top]

PCC CME Activities

Who Has the Ability to Consent?

La Vonne Ann Downey and Les Zun

Psychiatric Prodrome in Anti-NMDAR–Associated Encephalopathy: Clinical and Pathophysiologic Considerations

Anh-Vu Nguyen, Keith A. Young, James A. Bourgeois

Organic Psychosis Causing Secondary Schizophrenia in One-Fourth of a Cohort of 200 Patients Previously Diagnosed With Primary Schizophrenia

João Gama Marques

Glucagon-Like Peptide Analogs Are Superior for Diabetes and Weight Control in Patients on Antipsychotic Medications: A Retrospective Cohort Study

Lauren T. Perlis; J. Steven Lamberti; and Susanne U. Miedlich

Hypertensive Urgency and Emergency in Alcohol Withdrawal: A Literature Review

Ermal Bojdani, Anderson Chen, Tina Zhang, Nida Naqvi, Dil Tahera

No MMSE for You! A Case of an “Uncooperative” Patient With Early-Onset Dementia

Po-Heng Tsai, Gurmehr Kaur, Ganesh Gopalakrishna

Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics—HDC/DFMC Bridge Project, Phase 1: Group Concept Mapping

Keri Hager; Margarette Kading; Carolyn O’Donnell; Ann Yapel; Danielle MacDonald; Jennifer Nelson Albee; Cynthia Nash; Colleen Renier; Katherine Dean; and Mark Schneiderhan

Lithium Neurotoxicity Due to Second-Generation Antipsychotics Combined With Lithium: A Systematic Review

Ivan Netto, Vivek H. Phutane, and Bipin Ravindran

Posttraumatic Stress Disorder Symptoms, Functioning, and Suicidal Ideation in US Military Veterans: A Symptomics Approach

Lorig K. Kachadourian, Ilan Harpaz-Rotem, Jack Tsai, Steven M. Southwick, and Robert H. Pietrzak

Psychotropic Medication Monitoring: A Review

Matthew A. Schreiber, Stephanie C. Armstrong, and Jesse D. Markman

Stimulant Formulations for the Treatment of Attention-Deficit/Hyperactivity Disorder

Mohan Gautam and Deepak Prabhakar

Rates of Synthetic Cannabinoid Use in Adolescents Admitted to a Treatment Facility

Gloria Martz, William Tankersley, Hema Madhuri Mekala, and Huda Motiwala, MD